Charles River Laboratories International (CRL) Asset Writedowns and Impairment (2022 - 2025)

Charles River Laboratories International (CRL) has reported Asset Writedowns and Impairment for 4 consecutive years, with $7.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Asset Writedowns and Impairment fell 70.8% year-over-year to $7.9 million; the TTM figure through Dec 2025 stood at $12.4 million (down 64.67% YoY), while the FY2025 annual figure was $12.4 million, down 15.77% from the prior year.
• Asset Writedowns and Impairment came in at $7.9 million for Q4 2025 at Charles River Laboratories International, up from -$26.6 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $29.2 million in Q2 2025, with the low at -$26.6 million in Q3 2025.
• Average Asset Writedowns and Impairment over 4 years is $5.6 million, with a median of $6.7 million recorded in 2022.
• Across the five-year window, Asset Writedowns and Impairment jumped 1543.21% in 2024 and tumbled 342.08% in 2025, its largest moves.
• Year by year, Asset Writedowns and Impairment stood at $6.7 million in 2022, then sank by 218.95% to -$8.0 million in 2023, then jumped by 438.47% to $27.0 million in 2024, then plunged by 70.8% to $7.9 million in 2025.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $7.9 million, -$26.6 million, and $29.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.